Crossmark

Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy

Published Online: 2020-11-23

Published Print: 2021-02

Authors

Bi, Yanyu

Jiang, Yiming

Li, Xia

Hou, Guoxin

Li, Kesang https://orcid.org/0000-0002-2747-3831
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81602703)

Natural Science Foundation of Ningbo (2018A610382)

Zhejiang Medicine and Health Sciences Research Fund (2020379758)

2019 Jiaxing Key Discipline of Medicine-Oncolog (2019-zc-11)
License Information

Text and Data Mining valid from 2020-11-23

Version of Record valid from 2020-11-23
More Information

Article History

Received: 25 March 2020

Accepted: 8 October 2020

First Online: 23 November 2020

Compliance with ethical standards

:

: None.

Document is current